DK1458376T3 - Darifenacin til anvendelse i behandlingen af imperiös vandladningstrang fremkaldt af overaktiv urinblære - Google Patents
Darifenacin til anvendelse i behandlingen af imperiös vandladningstrang fremkaldt af overaktiv urinblæreInfo
- Publication number
- DK1458376T3 DK1458376T3 DK02702623T DK02702623T DK1458376T3 DK 1458376 T3 DK1458376 T3 DK 1458376T3 DK 02702623 T DK02702623 T DK 02702623T DK 02702623 T DK02702623 T DK 02702623T DK 1458376 T3 DK1458376 T3 DK 1458376T3
- Authority
- DK
- Denmark
- Prior art keywords
- urinary
- darifenacin
- imperious
- caused
- treatment
- Prior art date
Links
- 208000009722 Overactive Urinary Bladder Diseases 0.000 title abstract 2
- HXGBXQDTNZMWGS-RUZDIDTESA-N darifenacin Chemical compound C=1C=CC=CC=1C([C@H]1CN(CCC=2C=C3CCOC3=CC=2)CC1)(C(=O)N)C1=CC=CC=C1 HXGBXQDTNZMWGS-RUZDIDTESA-N 0.000 title abstract 2
- 229960002677 darifenacin Drugs 0.000 title abstract 2
- 230000002485 urinary effect Effects 0.000 title 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Document Processing Apparatus (AREA)
- Processing Of Meat And Fish (AREA)
- Inorganic Insulating Materials (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129962.7A GB0129962D0 (en) | 2001-12-14 | 2001-12-14 | Method of treatment |
| PCT/IB2002/000664 WO2003051354A1 (en) | 2001-12-14 | 2002-03-05 | Method of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1458376T3 true DK1458376T3 (da) | 2007-02-12 |
Family
ID=9927643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02702623T DK1458376T3 (da) | 2001-12-14 | 2002-03-05 | Darifenacin til anvendelse i behandlingen af imperiös vandladningstrang fremkaldt af overaktiv urinblære |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US20030130338A1 (cs) |
| EP (1) | EP1458376B1 (cs) |
| JP (3) | JP2005516925A (cs) |
| KR (1) | KR100889086B1 (cs) |
| CN (1) | CN100488505C (cs) |
| AT (1) | ATE341323T1 (cs) |
| AU (1) | AU2002236141B2 (cs) |
| BR (1) | BR0214925A (cs) |
| CA (1) | CA2469702C (cs) |
| CY (1) | CY1105814T1 (cs) |
| CZ (1) | CZ301283B6 (cs) |
| DE (1) | DE60215219T2 (cs) |
| DK (1) | DK1458376T3 (cs) |
| ES (1) | ES2276910T3 (cs) |
| GB (1) | GB0129962D0 (cs) |
| HU (1) | HU229908B1 (cs) |
| IL (2) | IL162391A0 (cs) |
| MX (1) | MXPA04005760A (cs) |
| NO (1) | NO20042586L (cs) |
| NZ (1) | NZ533421A (cs) |
| PL (1) | PL206034B1 (cs) |
| PT (1) | PT1458376E (cs) |
| RU (1) | RU2321398C2 (cs) |
| SI (1) | SI1458376T1 (cs) |
| SK (1) | SK287510B6 (cs) |
| WO (1) | WO2003051354A1 (cs) |
| ZA (1) | ZA200404289B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090062326A1 (en) * | 2006-03-17 | 2009-03-05 | Spindel Eliot R | M3 muscarinic receptor antagonists for treatment of m3 muscarinic receptor-expressing tumors |
| CN101084891A (zh) * | 2007-06-29 | 2007-12-12 | 北京本草天源药物研究院 | 一种用于口服的达非那新或其药用盐的药物制剂 |
| CZ200845A3 (cs) * | 2008-01-28 | 2009-09-02 | Zentiva, A. S. | Zpusob prípravy Darifenacinu |
| PL2394648T3 (pl) * | 2009-02-04 | 2016-12-30 | Kompozycja farmaceutyczna do podawania doustnego | |
| CN102048706B (zh) * | 2011-01-12 | 2012-02-22 | 山东创新药物研发有限公司 | 一种氢溴酸达非那新缓释片及制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
-
2001
- 2001-12-14 GB GBGB0129962.7A patent/GB0129962D0/en not_active Ceased
-
2002
- 2002-03-05 WO PCT/IB2002/000664 patent/WO2003051354A1/en active IP Right Grant
- 2002-03-05 RU RU2004121780/15A patent/RU2321398C2/ru active
- 2002-03-05 HU HU0402625A patent/HU229908B1/hu not_active IP Right Cessation
- 2002-03-05 SK SK250-2004A patent/SK287510B6/sk not_active IP Right Cessation
- 2002-03-05 DE DE60215219T patent/DE60215219T2/de not_active Expired - Lifetime
- 2002-03-05 DK DK02702623T patent/DK1458376T3/da active
- 2002-03-05 AT AT02702623T patent/ATE341323T1/de active
- 2002-03-05 AU AU2002236141A patent/AU2002236141B2/en not_active Expired
- 2002-03-05 PL PL369426A patent/PL206034B1/pl unknown
- 2002-03-05 BR BR0214925-7A patent/BR0214925A/pt active Search and Examination
- 2002-03-05 CN CNB028249364A patent/CN100488505C/zh not_active Expired - Lifetime
- 2002-03-05 MX MXPA04005760A patent/MXPA04005760A/es active IP Right Grant
- 2002-03-05 SI SI200230464T patent/SI1458376T1/sl unknown
- 2002-03-05 ES ES02702623T patent/ES2276910T3/es not_active Expired - Lifetime
- 2002-03-05 JP JP2003552287A patent/JP2005516925A/ja not_active Withdrawn
- 2002-03-05 NZ NZ533421A patent/NZ533421A/en not_active IP Right Cessation
- 2002-03-05 PT PT02702623T patent/PT1458376E/pt unknown
- 2002-03-05 IL IL16239102A patent/IL162391A0/xx unknown
- 2002-03-05 EP EP02702623A patent/EP1458376B1/en not_active Expired - Lifetime
- 2002-03-05 CZ CZ20040719A patent/CZ301283B6/cs not_active IP Right Cessation
- 2002-03-05 KR KR1020047009000A patent/KR100889086B1/ko not_active Expired - Lifetime
- 2002-03-05 CA CA2469702A patent/CA2469702C/en not_active Expired - Lifetime
- 2002-09-26 US US10/256,420 patent/US20030130338A1/en not_active Abandoned
-
2004
- 2004-06-01 ZA ZA2004/04289A patent/ZA200404289B/en unknown
- 2004-06-07 IL IL162391A patent/IL162391A/en active IP Right Grant
- 2004-06-18 NO NO20042586A patent/NO20042586L/no not_active Application Discontinuation
-
2006
- 2006-11-30 CY CY20061101729T patent/CY1105814T1/el unknown
-
2007
- 2007-07-19 US US11/880,006 patent/US20070264333A1/en not_active Abandoned
-
2009
- 2009-03-04 US US12/397,433 patent/US8748476B2/en not_active Expired - Lifetime
- 2009-10-30 JP JP2009250519A patent/JP2010024244A/ja not_active Withdrawn
-
2013
- 2013-07-11 JP JP2013145736A patent/JP2013199506A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1933833T3 (da) | Terapi til behandling af overaktiv blære | |
| DK1663244T3 (da) | Pteridin-derivater til behandling af TNF-alpha-beslægtede sygdomme | |
| CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
| WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| GB0002336D0 (en) | Medicaments | |
| MXPA03009273A (es) | AGENTE PARA EL TRATAMIENTO OFTaLMICO TOPICO DE LAS ENFERMEDADES INFLAMATORIAS OCULARES. | |
| DK1643999T3 (da) | Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes | |
| WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
| WO2004110420A8 (en) | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen | |
| DK1150704T3 (da) | Melagatran til behandling af betændelse | |
| CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| CY1105814T1 (el) | Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης | |
| BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| SE0200198D0 (sv) | New use | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| DK1530462T3 (da) | 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens | |
| DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
| EA200500774A1 (ru) | Новая синергетическая комбинация, включающая рофлумиласт и формотерол | |
| DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
| DK1368023T3 (da) | Anvendelse af buprenoprphin til behandling af urininkontinens | |
| BG108033A (bg) | Използване на 2-амино-1-(4-хидрокси-2-метансулфонамидофенил) етанол за лечение на инконтиненция | |
| HRP20050497B1 (hr) | Uporaba levocetirizina za liječenje stalnog alergijskog rinitisa |